TY - JOUR
T1 - DMD-related muscular dystrophy in Cameroon
T2 - Clinical and genetic profiles
AU - Wonkam-Tingang, Edmond
AU - Nguefack, Séraphin
AU - Esterhuizen, Alina I.
AU - Chelo, David
AU - Wonkam, Ambroise
N1 - Funding Information:
This study was supported by National Institutes of Health (NIH, USA, grant number: U01-HG-009716), African Academy of Science/Wellcome Trust (grant number: H3A/18/001). We are grateful to all patients and their parents, for their participation in this study. We acknowledge help from the staff of the pediatric neurology unit of the Gynaeco-Obstetric and Paediatric Hospital of Yaounde during the recruitment process. The authors also thank Dr. Kambe Banda, Dr. Jack Morrice, and Mrs. Caitlin Mcintosh, all from the Division of Human Genetics, Department of Pathology, University of Cape Town, South Africa for revising the manuscript.
Funding Information:
This study was supported by National Institutes of Health (NIH, USA, grant number: U01‐HG‐009716), African Academy of Science/Wellcome Trust (grant number: H3A/18/001).
Publisher Copyright:
© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Background: Most of the previous studies on Duchenne Muscular Dystrophy (DMD) were conducted in Caucasian, Asian, and Arab populations. Therefore, little is known about the features of this disease in Africans. In this study, we aimed to determine the clinical characteristics of DMD, and the common mutations associated with this condition in a group of Cameroonian patients. Methods: We recruited DMD patients and performed a general physical examination on each of them. Multiplex ligand-dependant probe amplification was carried out to investigate exon deletions and duplications in the DMD gene (OMIM: 300377) of patients and their mothers. Results: A total of 17 male patients from 14 families were recruited, aged 14 ± 5.1 (8–23) years. The mean age at onset of symptoms was 4.6 ± 1.5 years, and the mean age at diagnosis was 12.1 ± 5.2 years. Proximal muscle weakness was noted in all patients and calf hypertrophy in the large majority of them (88.2%; 15/17). Flexion contractures were particularly frequent on the ankle (85.7%; 12/14). Wasting of shoulder girdle and thigh muscles was present in 50% (6/12) and 46.2% (6/13) of patients, respectively. No patient presented with hearing impairment. Deletions in DMD gene (OMIM: 300377) occurred in 45.5% of patients (5/11), while duplications were observed in 27.3% (3/11). Both mutation types were clustered between exons 45 and 50, and the proportion of de novo mutation was estimated at 18.2% (2/11). Conclusion: Despite the first symptoms of DMD occurring in infancy, the diagnosis is frequently made later in adolescence, indicating an underestimation of the number of cases of DMD in Cameroon. Future screening of deletions and duplications in patients from Cameroon should focus on the distal part of the gene.
AB - Background: Most of the previous studies on Duchenne Muscular Dystrophy (DMD) were conducted in Caucasian, Asian, and Arab populations. Therefore, little is known about the features of this disease in Africans. In this study, we aimed to determine the clinical characteristics of DMD, and the common mutations associated with this condition in a group of Cameroonian patients. Methods: We recruited DMD patients and performed a general physical examination on each of them. Multiplex ligand-dependant probe amplification was carried out to investigate exon deletions and duplications in the DMD gene (OMIM: 300377) of patients and their mothers. Results: A total of 17 male patients from 14 families were recruited, aged 14 ± 5.1 (8–23) years. The mean age at onset of symptoms was 4.6 ± 1.5 years, and the mean age at diagnosis was 12.1 ± 5.2 years. Proximal muscle weakness was noted in all patients and calf hypertrophy in the large majority of them (88.2%; 15/17). Flexion contractures were particularly frequent on the ankle (85.7%; 12/14). Wasting of shoulder girdle and thigh muscles was present in 50% (6/12) and 46.2% (6/13) of patients, respectively. No patient presented with hearing impairment. Deletions in DMD gene (OMIM: 300377) occurred in 45.5% of patients (5/11), while duplications were observed in 27.3% (3/11). Both mutation types were clustered between exons 45 and 50, and the proportion of de novo mutation was estimated at 18.2% (2/11). Conclusion: Despite the first symptoms of DMD occurring in infancy, the diagnosis is frequently made later in adolescence, indicating an underestimation of the number of cases of DMD in Cameroon. Future screening of deletions and duplications in patients from Cameroon should focus on the distal part of the gene.
KW - Africa
KW - Cameroon
KW - Duchenne muscular dystrophy
KW - clinical patterns
KW - genetics
UR - http://www.scopus.com/inward/record.url?scp=85086440065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086440065&partnerID=8YFLogxK
U2 - 10.1002/mgg3.1362
DO - 10.1002/mgg3.1362
M3 - Article
C2 - 32543101
AN - SCOPUS:85086440065
SN - 2324-9269
VL - 8
JO - Molecular Genetics and Genomic Medicine
JF - Molecular Genetics and Genomic Medicine
IS - 8
M1 - e1362
ER -